IBDEI00O ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1070,1,3,0)
 ;;=3^Secondary malignant neoplasm of left lung
 ;;^UTILITY(U,$J,358.3,1070,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,1070,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,1071,0)
 ;;=C78.7^^10^75^12
 ;;^UTILITY(U,$J,358.3,1071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1071,1,3,0)
 ;;=3^Secondary malignant neoplasm of liver and intrahepatic bile duct
 ;;^UTILITY(U,$J,358.3,1071,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,1071,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,1072,0)
 ;;=C79.2^^10^75^19
 ;;^UTILITY(U,$J,358.3,1072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1072,1,3,0)
 ;;=3^Secondary malignant neoplasm of skin
 ;;^UTILITY(U,$J,358.3,1072,1,4,0)
 ;;=4^C79.2
 ;;^UTILITY(U,$J,358.3,1072,2)
 ;;=^267333
 ;;^UTILITY(U,$J,358.3,1073,0)
 ;;=C79.31^^10^75^4
 ;;^UTILITY(U,$J,358.3,1073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1073,1,3,0)
 ;;=3^Secondary malignant neoplasm of brain
 ;;^UTILITY(U,$J,358.3,1073,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,1073,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,1074,0)
 ;;=C79.32^^10^75^5
 ;;^UTILITY(U,$J,358.3,1074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1074,1,3,0)
 ;;=3^Secondary malignant neoplasm of cerebral meninges
 ;;^UTILITY(U,$J,358.3,1074,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,1074,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,1075,0)
 ;;=C79.49^^10^75^16
 ;;^UTILITY(U,$J,358.3,1075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1075,1,3,0)
 ;;=3^Secondary malignant neoplasm of oth parts of nervous system
 ;;^UTILITY(U,$J,358.3,1075,1,4,0)
 ;;=4^C79.49
 ;;^UTILITY(U,$J,358.3,1075,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,1076,0)
 ;;=C79.51^^10^75^2
 ;;^UTILITY(U,$J,358.3,1076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1076,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,1076,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,1076,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,1077,0)
 ;;=C79.52^^10^75^3
 ;;^UTILITY(U,$J,358.3,1077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1077,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone marrow
 ;;^UTILITY(U,$J,358.3,1077,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,1077,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,1078,0)
 ;;=C79.71^^10^75^17
 ;;^UTILITY(U,$J,358.3,1078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1078,1,3,0)
 ;;=3^Secondary malignant neoplasm of right adrenal gland
 ;;^UTILITY(U,$J,358.3,1078,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,1078,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,1079,0)
 ;;=C79.72^^10^75^10
 ;;^UTILITY(U,$J,358.3,1079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1079,1,3,0)
 ;;=3^Secondary malignant neoplasm of left adrenal gland
 ;;^UTILITY(U,$J,358.3,1079,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,1079,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,1080,0)
 ;;=C77.5^^10^75^8
 ;;^UTILITY(U,$J,358.3,1080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1080,1,3,0)
 ;;=3^Secondary malignant neoplasm of intrapelvic nodes
 ;;^UTILITY(U,$J,358.3,1080,1,4,0)
 ;;=4^C77.5
 ;;^UTILITY(U,$J,358.3,1080,2)
 ;;=^267319
 ;;^UTILITY(U,$J,358.3,1081,0)
 ;;=C48.2^^10^76^26
 ;;^UTILITY(U,$J,358.3,1081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1081,1,3,0)
 ;;=3^Malignant neoplasm of peritoneum, unspecified
 ;;^UTILITY(U,$J,358.3,1081,1,4,0)
 ;;=4^C48.2
 ;;^UTILITY(U,$J,358.3,1081,2)
 ;;=^5001122
 ;;^UTILITY(U,$J,358.3,1082,0)
 ;;=C45.0^^10^76^32
 ;;^UTILITY(U,$J,358.3,1082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1082,1,3,0)
 ;;=3^Mesothelioma of pleura
 ;;^UTILITY(U,$J,358.3,1082,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,1082,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,1083,0)
 ;;=C38.4^^10^76^27
 ;;^UTILITY(U,$J,358.3,1083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1083,1,3,0)
 ;;=3^Malignant neoplasm of pleura
 ;;^UTILITY(U,$J,358.3,1083,1,4,0)
 ;;=4^C38.4
 ;;^UTILITY(U,$J,358.3,1083,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,1084,0)
 ;;=C41.9^^10^76^18
 ;;^UTILITY(U,$J,358.3,1084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1084,1,3,0)
 ;;=3^Malignant neoplasm of bone and articular cartilage, unsp
 ;;^UTILITY(U,$J,358.3,1084,1,4,0)
 ;;=4^C41.9
 ;;^UTILITY(U,$J,358.3,1084,2)
 ;;=^5000993
 ;;^UTILITY(U,$J,358.3,1085,0)
 ;;=C49.9^^10^76^21
 ;;^UTILITY(U,$J,358.3,1085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1085,1,3,0)
 ;;=3^Malignant neoplasm of connective and soft tissue, unsp
 ;;^UTILITY(U,$J,358.3,1085,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,1085,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,1086,0)
 ;;=C47.9^^10^76^16
 ;;^UTILITY(U,$J,358.3,1086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1086,1,3,0)
 ;;=3^Malig neoplasm of prph nerves and autonm nervous sys, unsp
 ;;^UTILITY(U,$J,358.3,1086,1,4,0)
 ;;=4^C47.9
 ;;^UTILITY(U,$J,358.3,1086,2)
 ;;=^5001121
 ;;^UTILITY(U,$J,358.3,1087,0)
 ;;=C43.9^^10^76^17
 ;;^UTILITY(U,$J,358.3,1087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1087,1,3,0)
 ;;=3^Malignant melanoma of skin, unspecified
 ;;^UTILITY(U,$J,358.3,1087,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,1087,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,1088,0)
 ;;=D03.9^^10^76^31
 ;;^UTILITY(U,$J,358.3,1088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1088,1,3,0)
 ;;=3^Melanoma in situ, unspecified
 ;;^UTILITY(U,$J,358.3,1088,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,1088,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,1089,0)
 ;;=C44.01^^10^76^4
 ;;^UTILITY(U,$J,358.3,1089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1089,1,3,0)
 ;;=3^Basal cell carcinoma of skin of lip
 ;;^UTILITY(U,$J,358.3,1089,1,4,0)
 ;;=4^C44.01
 ;;^UTILITY(U,$J,358.3,1089,2)
 ;;=^340464
 ;;^UTILITY(U,$J,358.3,1090,0)
 ;;=C44.02^^10^76^36
 ;;^UTILITY(U,$J,358.3,1090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1090,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of lip
 ;;^UTILITY(U,$J,358.3,1090,1,4,0)
 ;;=4^C44.02
 ;;^UTILITY(U,$J,358.3,1090,2)
 ;;=^340465
 ;;^UTILITY(U,$J,358.3,1091,0)
 ;;=C44.310^^10^76^10
 ;;^UTILITY(U,$J,358.3,1091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1091,1,3,0)
 ;;=3^Basal cell carcinoma of skin of unspecified parts of face
 ;;^UTILITY(U,$J,358.3,1091,1,4,0)
 ;;=4^C44.310
 ;;^UTILITY(U,$J,358.3,1091,2)
 ;;=^5001043
 ;;^UTILITY(U,$J,358.3,1092,0)
 ;;=C44.311^^10^76^5
 ;;^UTILITY(U,$J,358.3,1092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1092,1,3,0)
 ;;=3^Basal cell carcinoma of skin of nose
 ;;^UTILITY(U,$J,358.3,1092,1,4,0)
 ;;=4^C44.311
 ;;^UTILITY(U,$J,358.3,1092,2)
 ;;=^5001044
 ;;^UTILITY(U,$J,358.3,1093,0)
 ;;=C44.319^^10^76^6
 ;;^UTILITY(U,$J,358.3,1093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1093,1,3,0)
 ;;=3^Basal cell carcinoma of skin of other parts of face
 ;;^UTILITY(U,$J,358.3,1093,1,4,0)
 ;;=4^C44.319
 ;;^UTILITY(U,$J,358.3,1093,2)
 ;;=^5001045
 ;;^UTILITY(U,$J,358.3,1094,0)
 ;;=C44.320^^10^76^42
 ;;^UTILITY(U,$J,358.3,1094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1094,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of unspecified parts of face
 ;;^UTILITY(U,$J,358.3,1094,1,4,0)
 ;;=4^C44.320
 ;;^UTILITY(U,$J,358.3,1094,2)
 ;;=^5001046
 ;;^UTILITY(U,$J,358.3,1095,0)
 ;;=C44.321^^10^76^37
 ;;^UTILITY(U,$J,358.3,1095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1095,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of nose
 ;;^UTILITY(U,$J,358.3,1095,1,4,0)
 ;;=4^C44.321
 ;;^UTILITY(U,$J,358.3,1095,2)
 ;;=^5001047
 ;;^UTILITY(U,$J,358.3,1096,0)
 ;;=C44.329^^10^76^38
 ;;^UTILITY(U,$J,358.3,1096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1096,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of other parts of face
 ;;^UTILITY(U,$J,358.3,1096,1,4,0)
 ;;=4^C44.329
 ;;^UTILITY(U,$J,358.3,1096,2)
 ;;=^5001048
 ;;^UTILITY(U,$J,358.3,1097,0)
 ;;=C44.41^^10^76^9
 ;;^UTILITY(U,$J,358.3,1097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1097,1,3,0)
 ;;=3^Basal cell carcinoma of skin of scalp and neck
 ;;^UTILITY(U,$J,358.3,1097,1,4,0)
 ;;=4^C44.41
 ;;^UTILITY(U,$J,358.3,1097,2)
 ;;=^340476
 ;;^UTILITY(U,$J,358.3,1098,0)
 ;;=C44.42^^10^76^41
 ;;^UTILITY(U,$J,358.3,1098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1098,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of scalp and neck
 ;;^UTILITY(U,$J,358.3,1098,1,4,0)
 ;;=4^C44.42
 ;;^UTILITY(U,$J,358.3,1098,2)
 ;;=^340477
 ;;^UTILITY(U,$J,358.3,1099,0)
 ;;=C44.510^^10^76^1
 ;;^UTILITY(U,$J,358.3,1099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1099,1,3,0)
 ;;=3^Basal cell carcinoma of anal skin
 ;;^UTILITY(U,$J,358.3,1099,1,4,0)
 ;;=4^C44.510
 ;;^UTILITY(U,$J,358.3,1099,2)
 ;;=^5001054
 ;;^UTILITY(U,$J,358.3,1100,0)
 ;;=C44.511^^10^76^2
 ;;^UTILITY(U,$J,358.3,1100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1100,1,3,0)
 ;;=3^Basal cell carcinoma of skin of breast
 ;;^UTILITY(U,$J,358.3,1100,1,4,0)
 ;;=4^C44.511
 ;;^UTILITY(U,$J,358.3,1100,2)
 ;;=^5001055
 ;;^UTILITY(U,$J,358.3,1101,0)
 ;;=C44.519^^10^76^7
 ;;^UTILITY(U,$J,358.3,1101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1101,1,3,0)
 ;;=3^Basal cell carcinoma of skin of other part of trunk
 ;;^UTILITY(U,$J,358.3,1101,1,4,0)
 ;;=4^C44.519
 ;;^UTILITY(U,$J,358.3,1101,2)
 ;;=^5001056
 ;;^UTILITY(U,$J,358.3,1102,0)
 ;;=C44.520^^10^76^33
 ;;^UTILITY(U,$J,358.3,1102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1102,1,3,0)
 ;;=3^Squamous cell carcinoma of anal skin
 ;;^UTILITY(U,$J,358.3,1102,1,4,0)
 ;;=4^C44.520
 ;;^UTILITY(U,$J,358.3,1102,2)
 ;;=^5001057
 ;;^UTILITY(U,$J,358.3,1103,0)
 ;;=C44.521^^10^76^34
 ;;^UTILITY(U,$J,358.3,1103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1103,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of breast
 ;;^UTILITY(U,$J,358.3,1103,1,4,0)
 ;;=4^C44.521
 ;;^UTILITY(U,$J,358.3,1103,2)
 ;;=^5001058
 ;;^UTILITY(U,$J,358.3,1104,0)
 ;;=C44.529^^10^76^39
 ;;^UTILITY(U,$J,358.3,1104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1104,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of other part of trunk
 ;;^UTILITY(U,$J,358.3,1104,1,4,0)
 ;;=4^C44.529
 ;;^UTILITY(U,$J,358.3,1104,2)
 ;;=^5001059
 ;;^UTILITY(U,$J,358.3,1105,0)
 ;;=C46.9^^10^76^15
 ;;^UTILITY(U,$J,358.3,1105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1105,1,3,0)
 ;;=3^Kaposi's sarcoma, unspecified
 ;;^UTILITY(U,$J,358.3,1105,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,1105,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,1106,0)
 ;;=C71.9^^10^76^19
 ;;^UTILITY(U,$J,358.3,1106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1106,1,3,0)
 ;;=3^Malignant neoplasm of brain, unspecified
 ;;^UTILITY(U,$J,358.3,1106,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,1106,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,1107,0)
 ;;=C72.1^^10^76^20
 ;;^UTILITY(U,$J,358.3,1107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1107,1,3,0)
 ;;=3^Malignant neoplasm of cauda equina
 ;;^UTILITY(U,$J,358.3,1107,1,4,0)
 ;;=4^C72.1
 ;;^UTILITY(U,$J,358.3,1107,2)
 ;;=^5001298
 ;;^UTILITY(U,$J,358.3,1108,0)
 ;;=C72.0^^10^76^28
 ;;^UTILITY(U,$J,358.3,1108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1108,1,3,0)
 ;;=3^Malignant neoplasm of spinal cord
 ;;^UTILITY(U,$J,358.3,1108,1,4,0)
 ;;=4^C72.0
 ;;^UTILITY(U,$J,358.3,1108,2)
 ;;=^267292
 ;;^UTILITY(U,$J,358.3,1109,0)
 ;;=C74.01^^10^76^23
 ;;^UTILITY(U,$J,358.3,1109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1109,1,3,0)
 ;;=3^Malignant neoplasm of cortex of right adrenal gland
 ;;^UTILITY(U,$J,358.3,1109,1,4,0)
 ;;=4^C74.01
 ;;^UTILITY(U,$J,358.3,1109,2)
 ;;=^5001312
 ;;^UTILITY(U,$J,358.3,1110,0)
 ;;=C74.02^^10^76^22
 ;;^UTILITY(U,$J,358.3,1110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1110,1,3,0)
 ;;=3^Malignant neoplasm of cortex of left adrenal gland
 ;;^UTILITY(U,$J,358.3,1110,1,4,0)
 ;;=4^C74.02
 ;;^UTILITY(U,$J,358.3,1110,2)
 ;;=^5001313
 ;;^UTILITY(U,$J,358.3,1111,0)
 ;;=C74.11^^10^76^25
 ;;^UTILITY(U,$J,358.3,1111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1111,1,3,0)
 ;;=3^Malignant neoplasm of medulla of right adrenal gland
 ;;^UTILITY(U,$J,358.3,1111,1,4,0)
 ;;=4^C74.11
 ;;^UTILITY(U,$J,358.3,1111,2)
 ;;=^5001315
 ;;^UTILITY(U,$J,358.3,1112,0)
 ;;=C74.12^^10^76^24
 ;;^UTILITY(U,$J,358.3,1112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1112,1,3,0)
 ;;=3^Malignant neoplasm of medulla of left adrenal gland
 ;;^UTILITY(U,$J,358.3,1112,1,4,0)
 ;;=4^C74.12
 ;;^UTILITY(U,$J,358.3,1112,2)
 ;;=^5001316
 ;;^UTILITY(U,$J,358.3,1113,0)
 ;;=C74.91^^10^76^30
 ;;^UTILITY(U,$J,358.3,1113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1113,1,3,0)
 ;;=3^Malignant neoplasm of unsp part of right adrenal gland
 ;;^UTILITY(U,$J,358.3,1113,1,4,0)
 ;;=4^C74.91
 ;;^UTILITY(U,$J,358.3,1113,2)
 ;;=^5001318
 ;;^UTILITY(U,$J,358.3,1114,0)
 ;;=C74.92^^10^76^29
 ;;^UTILITY(U,$J,358.3,1114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1114,1,3,0)
 ;;=3^Malignant neoplasm of unsp part of left adrenal gland
 ;;^UTILITY(U,$J,358.3,1114,1,4,0)
 ;;=4^C74.92
 ;;^UTILITY(U,$J,358.3,1114,2)
 ;;=^5001319
 ;;^UTILITY(U,$J,358.3,1115,0)
 ;;=C44.222^^10^76^40
 ;;^UTILITY(U,$J,358.3,1115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1115,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of right ear/external auric canal
 ;;^UTILITY(U,$J,358.3,1115,1,4,0)
 ;;=4^C44.222
 ;;^UTILITY(U,$J,358.3,1115,2)
 ;;=^5001035
 ;;^UTILITY(U,$J,358.3,1116,0)
 ;;=C44.229^^10^76^35
 ;;^UTILITY(U,$J,358.3,1116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1116,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of left ear/external auric canal
 ;;^UTILITY(U,$J,358.3,1116,1,4,0)
 ;;=4^C44.229
 ;;^UTILITY(U,$J,358.3,1116,2)
 ;;=^5001036
 ;;^UTILITY(U,$J,358.3,1117,0)
 ;;=C44.212^^10^76^8
 ;;^UTILITY(U,$J,358.3,1117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1117,1,3,0)
 ;;=3^Basal cell carcinoma of skin of right ear/external auric canal
 ;;^UTILITY(U,$J,358.3,1117,1,4,0)
 ;;=4^C44.212
 ;;^UTILITY(U,$J,358.3,1117,2)
 ;;=^5001032
 ;;^UTILITY(U,$J,358.3,1118,0)
 ;;=C44.219^^10^76^3
 ;;^UTILITY(U,$J,358.3,1118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1118,1,3,0)
 ;;=3^Basal cell carcinoma of skin of left ear/external auric canal
 ;;^UTILITY(U,$J,358.3,1118,1,4,0)
 ;;=4^C44.219
 ;;^UTILITY(U,$J,358.3,1118,2)
 ;;=^5001033
 ;;^UTILITY(U,$J,358.3,1119,0)
 ;;=C44.1191^^10^76^14
 ;;^UTILITY(U,$J,358.3,1119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1119,1,3,0)
 ;;=3^Basal cell cardinoma of skin of left upper eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1119,1,4,0)
 ;;=4^C44.1191
 ;;^UTILITY(U,$J,358.3,1119,2)
 ;;=^5157259
 ;;^UTILITY(U,$J,358.3,1120,0)
 ;;=C44.1192^^10^76^11
 ;;^UTILITY(U,$J,358.3,1120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1120,1,3,0)
 ;;=3^Basal cell carcinoma skin of left lower eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1120,1,4,0)
 ;;=4^C44.1192
 ;;^UTILITY(U,$J,358.3,1120,2)
 ;;=^5157260
 ;;^UTILITY(U,$J,358.3,1121,0)
 ;;=C44.1122^^10^76^12
 ;;^UTILITY(U,$J,358.3,1121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1121,1,3,0)
 ;;=3^Basal cell carcinoma skin of right lower eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1121,1,4,0)
 ;;=4^C44.1122
 ;;^UTILITY(U,$J,358.3,1121,2)
 ;;=^5157258
 ;;^UTILITY(U,$J,358.3,1122,0)
 ;;=C44.1121^^10^76^13
 ;;^UTILITY(U,$J,358.3,1122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1122,1,3,0)
 ;;=3^Basal cell carcinoma skin of right upper eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1122,1,4,0)
 ;;=4^C44.1121
 ;;^UTILITY(U,$J,358.3,1122,2)
 ;;=^5157257
 ;;^UTILITY(U,$J,358.3,1123,0)
 ;;=C44.1292^^10^76^43
 ;;^UTILITY(U,$J,358.3,1123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1123,1,3,0)
 ;;=3^Squamous cell carcinoma skin of left lower eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1123,1,4,0)
 ;;=4^C44.1292
 ;;^UTILITY(U,$J,358.3,1123,2)
 ;;=^5157264
 ;;^UTILITY(U,$J,358.3,1124,0)
 ;;=C44.1291^^10^76^44
 ;;^UTILITY(U,$J,358.3,1124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1124,1,3,0)
 ;;=3^Squamous cell carcinoma skin of left upper eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1124,1,4,0)
 ;;=4^C44.1291
 ;;^UTILITY(U,$J,358.3,1124,2)
 ;;=^5157263
 ;;^UTILITY(U,$J,358.3,1125,0)
 ;;=C44.1222^^10^76^45
 ;;^UTILITY(U,$J,358.3,1125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1125,1,3,0)
 ;;=3^Squamous cell carcinoma skin of right lower eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1125,1,4,0)
 ;;=4^C44.1222
 ;;^UTILITY(U,$J,358.3,1125,2)
 ;;=^5157262
 ;;^UTILITY(U,$J,358.3,1126,0)
 ;;=C44.1221^^10^76^46
 ;;^UTILITY(U,$J,358.3,1126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1126,1,3,0)
 ;;=3^Squamous cell carcinoma skin of right upper eyelid,incl canthus
 ;;^UTILITY(U,$J,358.3,1126,1,4,0)
 ;;=4^C44.1221
 ;;^UTILITY(U,$J,358.3,1126,2)
 ;;=^5157261
 ;;^UTILITY(U,$J,358.3,1127,0)
 ;;=C92.40^^10^77^21
 ;;^UTILITY(U,$J,358.3,1127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1127,1,3,0)
 ;;=3^Acute promyelocytic leukemia, not having achieved remission
 ;;^UTILITY(U,$J,358.3,1127,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,1127,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,1128,0)
 ;;=C92.50^^10^77^18
 ;;^UTILITY(U,$J,358.3,1128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1128,1,3,0)
 ;;=3^Acute myelomonocytic leukemia, not having achieved remission
 ;;^UTILITY(U,$J,358.3,1128,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,1128,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,1129,0)
 ;;=C92.00^^10^77^15
 ;;^UTILITY(U,$J,358.3,1129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1129,1,3,0)
 ;;=3^Acute myeloblastic leukemia, not having achieved remission
 ;;^UTILITY(U,$J,358.3,1129,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,1129,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,1130,0)
 ;;=C92.51^^10^77^17
 ;;^UTILITY(U,$J,358.3,1130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1130,1,3,0)
 ;;=3^Acute myelomonocytic leukemia, in remission
 ;;^UTILITY(U,$J,358.3,1130,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,1130,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,1131,0)
 ;;=C92.41^^10^77^20
 ;;^UTILITY(U,$J,358.3,1131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1131,1,3,0)
 ;;=3^Acute promyelocytic leukemia, in remission
 ;;^UTILITY(U,$J,358.3,1131,1,4,0)
 ;;=4^C92.41
 ;;^UTILITY(U,$J,358.3,1131,2)
 ;;=^5001802
 ;;^UTILITY(U,$J,358.3,1132,0)
 ;;=C92.01^^10^77^14
 ;;^UTILITY(U,$J,358.3,1132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1132,1,3,0)
 ;;=3^Acute myeloblastic leukemia, in remission
 ;;^UTILITY(U,$J,358.3,1132,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,1132,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,1133,0)
 ;;=C92.02^^10^77^13
 ;;^UTILITY(U,$J,358.3,1133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1133,1,3,0)
 ;;=3^Acute myeloblastic leukemia, in relapse
 ;;^UTILITY(U,$J,358.3,1133,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,1133,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,1134,0)
 ;;=C92.42^^10^77^19
 ;;^UTILITY(U,$J,358.3,1134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1134,1,3,0)
 ;;=3^Acute promyelocytic leukemia, in relapse
 ;;^UTILITY(U,$J,358.3,1134,1,4,0)
 ;;=4^C92.42
 ;;^UTILITY(U,$J,358.3,1134,2)
 ;;=^5001803
 ;;^UTILITY(U,$J,358.3,1135,0)
 ;;=C92.52^^10^77^16
 ;;^UTILITY(U,$J,358.3,1135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1135,1,3,0)
 ;;=3^Acute myelomonocytic leukemia, in relapse
 ;;^UTILITY(U,$J,358.3,1135,1,4,0)
 ;;=4^C92.52
 ;;^UTILITY(U,$J,358.3,1135,2)
 ;;=^5001806
 ;;^UTILITY(U,$J,358.3,1136,0)
 ;;=C92.10^^10^77^28
 ;;^UTILITY(U,$J,358.3,1136,1,0)
 ;;=^358.31IA^4^2
